scholarly journals Safety of a new extensively hydrolysed formula in children with cow's milk protein allergy: a double blind crossover study

2002 ◽  
Vol 2 (1) ◽  
Author(s):  
Suzanne WJ Terheggen-Lagro ◽  
Ilse MSL Khouw ◽  
Anne Schaafsma ◽  
Erik AK Wauters
PEDIATRICS ◽  
1989 ◽  
Vol 83 (2) ◽  
pp. 262-266 ◽  
Author(s):  
Lasse Lothe ◽  
Tor Lindberg

There are several causes of infantile colic. The aim of this study was to evaluate, under controlled conditions, whether bovine whey proteins can elicit symptoms of infantile colic in colicky formula-fed infants. The mean age for entering the study was 6.4 weeks and the mean age for colic debut was 3.7 weeks. In 24 of 27 infants with severe colic, the symptoms disappeared when they were given a cow's milk-free diet (Nutramigen). These 24 infants were entered into a double-blind crossover study. The infants (receiving cow's milk-free diet) were given the contents of identical capsules with each meal during day 6. The same procedure was repeated on day 10. The capsules contained either whey protein powder (with Nutramigen added) or human albumin powder (with Nutramigen added). Eighteen infants receiving the whey protein-containing capsules reacted with colic, two infants receiving placebo reacted with colic (P< .001), and four infants did not react at all. Crying hours per day for the 24 infants were 5.6 hours for formula-fed infants and 0.7 hour for cow's milk-free diet-fed infants (P< .001). Crying hours per day were 3.2 hours for the infants receiving whey protein capsules and 1.0 hour for those receiving placebo (P< .001). In conclusion, bovine whey protein can elicit symptoms of infantile colic in colicky formula-fed infants.


PEDIATRICS ◽  
1989 ◽  
Vol 84 (1) ◽  
pp. 17-17

In the article, "Cow's Milk Whey Protein Elicits Symptoms of Infantile Colic in Colicky Formula-Fed Infants: A Double-Blind Crossover Study," by Lothe and Lindberg (Pediatrics 1989;83:262-266), there was an error on page 264. The second sentence in "Results" should have read: Infants receiving cow's milkbased formula cried 3 h/d or more.


2013 ◽  
Vol 102 (10) ◽  
pp. 990-998 ◽  
Author(s):  
Yvan Vandenplas ◽  
Philippe Steenhout ◽  
Yannis Planoudis ◽  
Dominik Grathwohl ◽  

Author(s):  
Gennadiy A. Novik ◽  
Maria V. Zhdanova ◽  
Yulia O. Zaitseva ◽  
Anastasiia S. Demidova

Well-recognized tactic for the management of formula-fed children with cow’s milk protein allergy (CMPA) is exclusion of whole cow milk protein and its replacement with extensively hydrolyzed or amino acid formula. One of the most topical issue is the choice of therapeutic formula for a child with CMPA. This article presents information about the clinical manifestations of CMPA and describes the principles of nutrition therapy. All the stages of preparation of adapted therapeutic formula are discussed in detail. It has been shown that the choice of therapeutic formula for a child with CMPA depends on the disease clinical manifestations, their severity, and the presence of comorbid conditions. Current requirements for extensively hydrolyzed formula are reduced to limitations in the size of peptides with immunoreactive properties and indicate the need for evidence of the clinical efficacy of such formula in double-blind placebo-controlled studies.


1993 ◽  
Vol 69 (3) ◽  
pp. 863-870 ◽  
Author(s):  
Elizabeth J. Brink ◽  
Emerentia C. H. van Beresteijn ◽  
Pieter R. Dekker ◽  
Anton C. Beynen

The effect of lactose on the urinary excretion of Mg and Ca, as an index of absorption, was studied in a double-blind, crossover study during three 1-week periods. Twenty-four healthy, lactose-tolerant, adult volunteers maintained their habitual diets with the exception that all lactose-containing dairy products in the diet were replaced by 600 g/d of three specially prepared dairy products. These products were based on either lactose-enriched cow's milk or lactose-enriched, lactase (EC3.2.1.23)-treated cow's milk, with or without added Mg, and were given in turn during 1 week. Lactose intake was increased by 127 mmol/d (46 g/d) while taking the lactose-enriched products. While taking the Mg-enriched products, Mg intake was increased by 2.8 mmol/d (69 mg/d) which was equivalent to 17% of the habitual Mg intake. Apart from the lactose and Mg intake, nutrient intake was comparable during the three dietary periods. Urinary excretions of Mg and Ca were used as indicators for their absorption. Mg supplementation significantly increased urinary Mg excretion by 0.97 mmol/d (equivalent to an increase of 18%,P< 0.001), indicating that urinary Mg excretion is a valid indicator for intestinal Mg absorption. Hydrolysis of lactose did not affect urinary excretion of Mg and Ca, which implies that lactose intake does not affect the absorption of Mg and Ca in healthy adults.


2010 ◽  
Vol 21 (4p1) ◽  
pp. 577-585 ◽  
Author(s):  
M. Reche ◽  
C. Pascual ◽  
A. Fiandor ◽  
I. Polanco ◽  
M. Rivero-Urgell ◽  
...  

PEDIATRICS ◽  
1983 ◽  
Vol 72 (2) ◽  
pp. 267-267
Author(s):  
G. B. Stickler

After reading the article by Jakobsson and Lindberg "Cow's Milk Proteins Cause Infantile Colic in Breast-Fed Infants: A Double-Blind Crossover Study" (Pediatrics 1983;71:268-271), I am wondering a little bit what is happening to the review process. The study supposedly shows experience with 66 breast-fed infants. However, the critical double-blind crossover trial was completed successfully only with ten. It is not clear why the article was published including 50 children who were not studied objectively. I do believe a paper of this sort will cause a great deal of alarm on data based on much to small a sample.


1979 ◽  
Vol 42 (02) ◽  
pp. 621-625 ◽  
Author(s):  
G G Nenci ◽  
G Agnelli ◽  
M Berrettini ◽  
P Parise ◽  
E Ballatori

SummaryIn a randomized double-blind crossover study in 16 patients with enhanced in vitro spontaneous platelet aggregation, sulfinpyrazone proved to be effective in normalizing platelet aggregability within 4 days after initiation of therapy.


Sign in / Sign up

Export Citation Format

Share Document